featured
T-DM1 Efficacy in Patients With HER2-Positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Breast Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
T-DM1 Efficacy in Patients With HER2-Positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study
Clin. Breast Cancer 2019 Oct 24;[EPub Ahead of Print], B Conte, A Fabi, F Poggio, E Blondeaux, C Dellepiane, A D'Alonzo, G Buono, G Arpino, V Magri, G Naso, D Presti, S Mura, A Fontana, F Cognetti, C Molinelli, S Pastorino, C Bighin, L Miglietta, F Boccardo, M Lambertini, L Del MastroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.